NCT05033392View on ClinicalTrials.gov

PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Stomach Neoplasms
Interventions
DRUG

Toripalimab Injection

A domestic PD-1 antibody

Trial Locations (2)

518020

RECRUITING

Shenzhen People's Hospital, Shenzhen

Unknown

RECRUITING

Shenzhen People's Hospital, Shenzhen

All Listed Sponsors
lead

Wan He

OTHER